General MedicationsORALGeneric
KETOPROFEN
KETOPROFEN
Standard Dose
100MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary
Approval overview KETOPROFEN is listed in Drugs@FDA under application 075679 (ANDA).
Review priority: STANDARD Marketing status: Discontinued Active ingredient KETOPROFEN Form and strength CAPSULE, EXTENDED RELEASE;ORAL - 100MG Sponsor MYLAN Submission history Latest submission status date: 2024-11-21 00:00:00.
Structured Monograph
Clinical summary
Approval overview KETOPROFEN is listed in Drugs@FDA under application 075679 (ANDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient KETOPROFEN Form and strength CAPSULE, EXTENDED RELEASE;ORAL - 100MG Sponsor MYLAN Submission history Latest submission status date: 2024-11-21 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Discontinued
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.